Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Ravaud

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
The New England Journal of Medicine|February 22, 2021
A Step Ahead in Metastatic Renal Cell CarcinomaAlain Ravaud
Bulletin Du Cancer|November 12, 2003
[Cell therapy in renal cell carcinoma]Alain Ravaud
International Journal of Urology : Official Journal of the Japanese Urological Association|June 2, 2012
Editorial comment to therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinomaAlain Ravaud
Asia-Pacific Journal of Clinical Oncology|November 30, 2018
Adjuvant therapy after nephrectomy for renal cell carcinomaAlain Ravaud
The Oncologist|February 25, 2011
Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapiesAlain Ravaud
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 19, 2007
[The mechanism of tumor angiogenesis]Alain Ravaud
The New England Journal of Medicine|March 2, 2017
Adjuvant Sunitinib in Renal-Cell CarcinomaAlain Ravaud
The Lancet. Oncology|April 3, 2010
Metronomic chemotherapy for renal cancer in the landscape of targeted therapyAlain Ravaud, Marine Grossgoupil
Bulletin Du Cancer|June 24, 2010
[Bladder cancer. Editorial]Christophe Massard, Alain Ravaud
World Journal of Urology|January 11, 2014
Systemic therapy of renal cell carcinomaViktor Grünwald, Alain Ravaud
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
The New England Journal of Medicine|February 22, 2021
A Step Ahead in Metastatic Renal Cell CarcinomaAlain Ravaud
Bulletin Du Cancer|November 12, 2003
[Cell therapy in renal cell carcinoma]Alain Ravaud
International Journal of Urology : Official Journal of the Japanese Urological Association|June 2, 2012
Editorial comment to therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinomaAlain Ravaud
Asia-Pacific Journal of Clinical Oncology|November 30, 2018
Adjuvant therapy after nephrectomy for renal cell carcinomaAlain Ravaud
The Oncologist|February 25, 2011
Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapiesAlain Ravaud
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 19, 2007
[The mechanism of tumor angiogenesis]Alain Ravaud
The New England Journal of Medicine|March 2, 2017
Adjuvant Sunitinib in Renal-Cell CarcinomaAlain Ravaud
The Lancet. Oncology|April 3, 2010
Metronomic chemotherapy for renal cancer in the landscape of targeted therapyAlain Ravaud, Marine Grossgoupil
Bulletin Du Cancer|June 24, 2010
[Bladder cancer. Editorial]Christophe Massard, Alain Ravaud
World Journal of Urology|January 11, 2014
Systemic therapy of renal cell carcinomaViktor Grünwald, Alain Ravaud
Pageof 23